SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : $2 or higher gas - Can ethanol make a comeback?
DAR 60.71+2.0%Jun 27 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: richardred9/20/2013 10:12:57 AM
   of 2801
 
BASF buying biotechnology company Verenium for about $51.2 million




SAN DIEGO (AP) -- Chemicals company BASF Corp. is buying biotechnology company Verenium for approximately $51.2 million.

Verenium focuses on developing and selling high-performance enzymes used in food and fuel markets. BASF is a diversified company whose products range from chemicals, plastics and performance and crop protection products to oil and gas.

BASF will pay $4 per share for Verenium, which is a 59 percent premium to its Thursday closing price of $2.51.

Verenium Corp., based in San Diego, currently has about 12.8 million outstanding shares, according to FactSet.

A tender offer related to the transaction is expected to close in the fourth quarter.

Both companies' boards approved the deal.

finance.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext